Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2566 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Nihon Kohden acquires Neurotronics

Neurotronics becomes a subsidiary of Nihon Kohden on December 31, 2008. Nihon Kohden is expected to strengthen its position as a leader in the neurology business with the

NovaDel wins FDA approval for insomnia drug

Zolpimist is NovaDel’s second product approved by the FDA that uses the company’s proprietary NovaMist oral spray technology. Zolpimist contains zolpidem tartrate, the same active ingredient as Ambien,

Paladin Labs acquires ViRexx Medical

ViRexx has three proprietary technology platforms Chimigen vaccine platform, T-ACT platform and the AIT platform. The Chimigen platform is a versatile platform technology being used primarily to generate